ArticleJournal of animal science and technology2026
Identification of the optimal monosodium glutamate-condensed molasses solubles inclusion level replacing molasses in growing-finishing pigs.
Article in Journal of animal science and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the effects of replacing molasses with monosodium glutamate (MSG)-condensed molasses solubles (CMS) in growing-finishing pig diets and determine the optimal replacement ratio. Experiment 1, a total of 100 crossbred growing-finishing pigs ([Landrace × Yorkshire] × Duroc) (9 weeks of age; initial body weight 23.17 ± 3.51 kg) were randomly assigned to five dietary treatments for 14 weeks, with four replicates per treatment and five pigs per replicate. The treatments consisted of: (1) PC (basal diet with 2% molasses), (2) NC (basal diet), (3) T1 (basal diet with 1.5% molasses + 0.5% MSG-CMS), (4) T2 (basal diet with 1% molasses + 1% MSG-CMS), and (5) T3 (basal diet with 2% MSG-CMS). Growth performance, nutrient digestibility, blood profiles, fecal microbiota, and economic efficiency were assessed. Average daily gain in the T1 was higher (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.